Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 1Polycystic Ovary Syndrome 1Oligomenorrhea 1Insulin Resistance 1Hyperandrogenism 1Hirsutism 1Esophageal Neoplasms 1Diabetes Mellitus, Type 1 1Cognitive Dysfunction 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Exercise 6Transcranial Direct Current Stimulation 4Neuropsychological Tests 4Walking 3Memantine 3Tablets 2Standard of Care 2Patient Reported Outcome Measures 2Methods 2Electroencephalography 2Drug Therapy 2Donepezil 2Cognitive Behavioral Therapy 2mazdutide 1lithium sulfate 1lime 1fasudil 1enzalutamide 1blueberry extract 1beta Carotene 1acetaminophen, aspirin, caffeine drug combination 1XENP 1595 1Vitamin E 1Vitamin D 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Time 1Therapeutics 1Tai Ji 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Time × Clear all
NCT04669301 2025-07-15

Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II

University of Rochester

Phase NA Completed
72 enrolled 15 charts

Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡